急性髓性白血病的悖论 响应于采用T细胞疗法
1Gates Institute; Pediatrics and Immunology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Blood cancer discovery
|April 16, 2025
概括
急性髓性白血病 (AML) 是T细胞免疫治疗的目标,但生物障碍阻碍了治疗的成功. 最近的研究揭示了AML抵抗T细胞中介杀伤的机制,影响治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 急性髓性白血病 (AML) 被认为是一种易受T细胞向的恶性瘤.
- 尽管如此,T细胞免疫治疗AML的临床成功速度比预期慢.
研究的目的:
- 讨论阻碍AML有效T细胞治疗的生物障碍.
- 提供对AML抵抗T细胞中介杀伤的机制性见解.
主要方法:
- 审查最近关于AML耐药性的报告和机制研究.
- 对导致治疗失败的生物学因素的分析.
主要成果:
- 确定限制T细胞在AML中的疗效的特定生物障碍.
- 阐明AML细胞抵抗T细胞介导杀死的机制.
结论:
- 了解这些抵抗机制对于推进AML免疫疗法至关重要.
- 克服这些障碍可能会改善急性髓性白血病患者的治疗结果.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.3K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.2K
相关概念视频
Cell-mediated Immune Responses
65.8K
Overview
65.8K
Tumor Immunotherapy
404
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
404
Bone Marrow Sampling and Transplants
263
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
263
Cytotoxic T Cells-mediated Immune Response
736
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
736
